SCHEMBL23988388

SCHEMBL23988388

Cc1cnc(C[S@@+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c(C)c1OCC(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SARM1 Q6SZW1 2/20 0.45
ATP1A1 P05023 2/20 0.32
ATP1B1 P05026 2/20 0.32
ATP1A3 P13637 2/20 0.32
ATP1B2 P14415 2/20 0.32
ATP4A P20648 2/20 0.32
ATP1A2 P50993 2/20 0.32
ATP4B P51164 2/20 0.32
ATP1B3 P54709 2/20 0.32
FXYD2 P54710 2/20 0.32
ATP1A4 Q13733 2/20 0.32
WDR5 P61964 3/20 0.32
KMT2A Q03164 3/20 0.32
NPC1 O15118 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
RAB9A P51151 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23988387 1.00 SARM1 (0.45) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988426 1.00 SARM1 (0.45) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988470 0.90 WDR5 (0.33) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988289 0.89 KMT2A (0.41) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988511 0.89 KMT2A (0.41) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988288 0.89 KMT2A (0.41) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL8977361 0.86 SARM1 (0.41) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988451 0.85 CYP2C9 (0.46) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23988409 0.85 CYP2C9 (0.46) SARM1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL8472843 0.85 CYP2C9 (0.46) SARM1ATP1A1ATP1B1ATP1A3ATP1B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220202796-A1 CXCL10 Inhibitors LAPKO INC, dba AFECTA PHARMACEUTICALS 2022-06-30 US disclosed
US-20210338650-A1 CXCL10 Inhibitors AFECTA PHARMACEUTICALS, INC. (US) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220202796-A1 CXCL10 Inhibitors CXCL10, CCL5, CCL11 SARM1 3076/4885ATP1A1 4691/4885ATP1B1 4715/4885
US-20210338650-A1 CXCL10 Inhibitors CXCL10, CCL5, CCL11 SARM1 3076/4885ATP1A1 4691/4885ATP1B1 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.